Mezigdomide (MEZI) Plus Dexamethasone (DEX) and Bortezomib (BORT) or Carfilzomib (CFZ) in Patients With Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results From the CC-92480-MM-002 Trial
Por:
Sandhu, I, Richardson, PG, Oriol, A, White, D, Leblanc, R, Raje, N, Ocio, EM, Perrot, A, Facon, T, Rodriguez, C, Wäsch, R, Dimopoulos, MA, Chow, TT, Gaudy, A, Gong, J, Zhou, ZH, Civardi, T, Hadala, JT, Zhu, Y, Katz, J and Raab, MS
Publicada:
1 sep 2025
Resumen:
Filiaciones:
Sandhu, I:
Univ Alberta, Edmonton, AB, Canada
Richardson, PG:
Dana Farber Canc Inst, Boston, MA USA
:
Hosp Germans Trias i Pujol, Catalan Inst Oncol, Badalona, Spain
Hosp Germans Trias i Pujol, Josep Carreras Inst, Badalona, Spain
White, D:
Dalhousie Univ, Halifax, NS, Canada
Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada
Leblanc, R:
Univ Montreal, Hop Maisonneuve Rosemont, Montreal, PQ, Canada
Raje, N:
Massachusetts Gen Hosp, Boston, MA USA
Ocio, EM:
Univ Cantabria, Hosp Univ Marques Valdecilla IDIVAL, Santander, Spain
Perrot, A:
Inst Univ Canc Toulouse Oncopole, Toulouse, France
Facon, T:
Univ Lille, CHU Lille, Serv Malad Sang, Lille, France
Rodriguez, C:
Icahn Sch Med Mt Sinai, New York, NY USA
Wäsch, R:
Univ Freiburg, Med Ctr, Dept Med, Freiburg, Germany
Dimopoulos, MA:
Natl & Kapodistrian Univ Athens, Athens, Greece
Chow, TT:
Bristol Myers Squibb, Princeton, NJ USA
Gaudy, A:
Bristol Myers Squibb, Princeton, NJ USA
Gong, J:
Bristol Myers Squibb, Princeton, NJ USA
Zhou, ZH:
Bristol Myers Squibb, Princeton, NJ USA
Civardi, T:
Bristol Myers Squibb Co, Celgene Int Sarl, Boudry, Switzerland
Hadala, JT:
Bristol Myers Squibb, Princeton, NJ USA
Zhu, Y:
Bristol Myers Squibb, Princeton, NJ USA
Katz, J:
Bristol Myers Squibb, Princeton, NJ USA
Raab, MS:
Heidelberg Univ Hosp, Heidelberg Myeloma Ctr, Dept Med 5, Heidelberg, Germany
|